Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
about
Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells.Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapySpecific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy.Bridging to liver transplantation in HCC patients.
P2860
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@ast
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@en
type
label
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@ast
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@en
prefLabel
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@ast
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@en
P2093
P2860
P356
P1433
P1476
Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.
@en
P2093
Charles L Wiggins
Helen M Parsons
Jennifer L Stevens
Linda C Harlan
Yehuda Z Patt
P2860
P356
10.1159/000367729
P577
2015-03-01T00:00:00Z